Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 4
Submit an article Journal homepage
497
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer

J Aguilar-Serraa Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, SpainCorrespondence[email protected]
View further author information
,
V Gimeno-Ballesterb Department of Pharmacy, Hospital Universitario Miguel Servet, Zaragoza, SpainView further author information
,
a Pastor-Cleriguesa Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain;c Department of Pharmacy, University General Hospital Consortium, Valencia, SpainView further author information
,
J Milaraa Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain;c Department of Pharmacy, University General Hospital Consortium, Valencia, Spain;d Department of Pharmacy, Research Foundation of General Hospital of Valencia, Valencia, Spain;e CIBERES, Health Institute Carlos III, Valencia, SpainView further author information
,
C Trigo-Vicentef Department of Pharmacy, C.r.p. Nuestra Señora Del Pilar, Zaragoza, Spain;g Department of Pharmacy, Universidad San Jorge, Zaragoza, SpainView further author information
&
J Cortijoa Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain;c Department of Pharmacy, University General Hospital Consortium, Valencia, Spain;e CIBERES, Health Institute Carlos III, Valencia, SpainView further author information
Pages 637-646 | Received 20 Aug 2021, Accepted 27 Sep 2021, Published online: 11 Oct 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lisa M. Hess, Diane Michael, Peter M. Krein, Tyler Marquart & Anthony N. Sireci. (2023) Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database study. Journal of Medical Economics 26:1, pages 43-50.
Read now

Articles from other publishers (1)

Chan Shen, Rolfy A. Perez Holguin, Eric Schaefer, Shouhao Zhou, Chandra P. Belani, Patrick C. Ma & Michael F. Reed. (2022) Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma. BMC Health Services Research 22:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.